Aaron Goldman

7PUBLICATIONS
17CO-AUTHORS
Cancer cell biologyNanomedicineMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 04, 2026
Optimal cannabinoid-terpene combination ratios suppress mutagenicity of gastric reflux in normal and metaplastic esophageal cells.

|Oct 03, 2025
Optimal Cannabinoid-Terpene Combination Ratios Suppress Mutagenicity of Gastric Reflux in Normal and Metaplastic Esophageal Cells.

Aaron Goldman, Gabriel Gonzalez, Svetlana A Karpova

|Sep 30, 2021
Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer.

Tanmoy Saha, Jayanta Mondal, Sachin Khiste

|Jul 16, 2021
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade.

Michelle Przedborski, Munisha Smalley, Saravanan Thiyagarajan

|Nov 05, 2020
Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling.

Morgan Craig, Adrianne L Jenner, Bumseok Namgung

|Aug 27, 2019
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer.

Morgan Craig, Kamran Kaveh, Alec Woosley

Pageof 2

Frequent Collaborators

2 joint publications

Andrew Dhawan

2 joint publications

Elliot Eton

2 joint publications

Morgan Craig

1 joint publications

Jayanta Mondal